RadNet Price to Free Cash Flow Ratio 2012-2026 | RDNT
Historical price to free cash flow ratio values for RadNet (RDNT) since 2012.
| RadNet Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-12 | 56.71 | 0.00 | |
| 2025-12-31 | 71.35 | 0 | 0.00 |
| 2025-09-30 | 76.21 | $0.68 | 112.60 |
| 2025-06-30 | 56.91 | $1.00 | 56.68 |
| 2025-03-31 | 49.72 | $1.09 | 45.76 |
| 2024-12-31 | 69.84 | $0.60 | 115.74 |
| 2024-09-30 | 69.39 | $1.36 | 51.15 |
| 2024-06-30 | 58.92 | $0.99 | 59.37 |
| 2024-03-31 | 48.66 | $0.51 | 95.81 |
| 2023-12-31 | 34.77 | $0.69 | 50.69 |
| 2023-09-30 | 28.19 | $0.52 | 54.00 |
| 2023-06-30 | 32.62 | $0.68 | 48.26 |
| 2023-03-31 | 25.03 | $0.77 | 32.70 |
| 2022-12-31 | 18.83 | $0.54 | 34.97 |
| 2022-09-30 | 20.35 | $-0.05 | 0.00 |
| 2022-06-30 | 17.28 | $0.08 | 220.13 |
| 2022-03-31 | 22.37 | $-0.36 | 0.00 |
| 2021-12-31 | 30.11 | $0.23 | 131.37 |
| 2021-09-30 | 29.31 | $1.18 | 24.78 |
| 2021-06-30 | 33.69 | $1.52 | 22.20 |
| 2021-03-31 | 21.75 | $2.91 | 7.47 |
| 2020-12-31 | 19.57 | $2.76 | 7.09 |
| 2020-09-30 | 15.35 | $2.13 | 7.21 |
| 2020-06-30 | 15.87 | $2.06 | 7.69 |
| 2020-03-31 | 10.51 | $0.53 | 19.67 |
| 2019-12-31 | 20.30 | $0.62 | 32.56 |
| 2019-09-30 | 14.36 | $0.70 | 20.50 |
| 2019-06-30 | 13.79 | $0.79 | 17.45 |
| 2019-03-31 | 12.39 | $0.82 | 15.20 |
| 2018-12-31 | 10.17 | $0.97 | 10.44 |
| 2018-09-30 | 15.05 | $1.82 | 8.28 |
| 2018-06-30 | 15.00 | $1.66 | 9.04 |
| 2018-03-31 | 14.40 | $1.77 | 8.12 |
| 2017-12-31 | 10.10 | $1.73 | 5.82 |
| 2017-09-30 | 11.55 | $1.14 | 10.10 |
| 2017-06-30 | 7.75 | $0.63 | 12.26 |
| 2017-03-31 | 5.90 | $0.76 | 7.80 |
| 2016-12-31 | 6.45 | $0.71 | 9.07 |
| 2016-09-30 | 7.40 | $0.58 | 12.65 |
| 2016-06-30 | 5.34 | $0.89 | 5.98 |
| 2016-03-31 | 4.83 | $0.59 | 8.21 |
| 2015-12-31 | 6.18 | $0.57 | 10.82 |
| 2015-09-30 | 5.55 | $0.50 | 11.21 |
| 2015-06-30 | 6.69 | $0.55 | 12.08 |
| 2015-03-31 | 8.40 | $0.97 | 8.67 |
| 2014-12-31 | 8.54 | $0.47 | 18.10 |
| 2014-09-30 | 6.62 | $0.49 | 13.59 |
| 2014-06-30 | 6.63 | $0.37 | 17.75 |
| 2014-03-31 | 2.84 | $-0.05 | 0.00 |
| 2013-12-31 | 1.67 | $0.56 | 2.97 |
| 2013-09-30 | 2.41 | $0.39 | 6.19 |
| 2013-06-30 | 2.65 | $0.44 | 5.96 |
| 2013-03-31 | 2.80 | $0.84 | 3.34 |
| 2012-12-31 | 2.53 | $0.88 | 2.86 |
| 2012-09-30 | 2.78 | $0.98 | 2.84 |
| 2012-06-30 | 2.66 | $0.90 | 2.96 |
| 2012-03-31 | 3.18 | $0.51 | 6.25 |
| 2011-12-31 | 2.13 | $0.39 | 5.42 |
| 2011-09-30 | 2.44 | $0.28 | 8.73 |
| 2011-06-30 | 4.40 | $0.65 | 6.76 |
| 2011-03-31 | 3.50 | $0.63 | 5.53 |
| 2010-12-31 | 2.82 | $0.74 | 3.81 |
| 2010-09-30 | 2.40 | $1.00 | 2.40 |
| 2010-06-30 | 2.37 | $0.86 | 2.75 |
| 2010-03-31 | 3.18 | $1.13 | 2.83 |
| 2009-12-31 | 2.04 | $1.30 | 1.57 |
| 2009-09-30 | 2.59 | $1.26 | 2.06 |
| 2009-06-30 | 2.25 | $1.22 | 1.85 |
| 2009-03-31 | 1.24 | $1.15 | 1.07 |
| 2008-12-31 | 3.35 | $0.54 | 6.23 |
| 2008-09-30 | 4.01 | $-0.06 | 0.00 |
| 2008-06-30 | 6.20 | $-0.26 | 0.00 |
| 2008-03-31 | 7.04 | $-0.50 | 0.00 |
| 2007-12-31 | 10.15 | $-0.03 | 0.00 |
| 2007-09-30 | 8.90 | $-0.03 | 0.00 |
| 2007-06-30 | 9.53 | $-0.05 | 0.00 |
| 2007-03-31 | 5.71 | $0.12 | 46.23 |
| 2006-12-31 | 4.62 | $-0.24 | 0.00 |
| 2006-10-31 | 5.14 | $-0.11 | 0.00 |
| 2006-09-30 | 5.44 | $-0.14 | 0.00 |
| 2006-07-31 | 3.40 | $-0.07 | 0.00 |
| 2006-06-30 | 3.50 | $0.26 | 13.57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.302B | $2.040B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |